Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vibrio vulnificus septicemia in a patient with liver cirrhosis.
Chan TY, Chow DP, Ng KC, Pang KW, McBride GA. Chan TY, et al. Among authors: chow dp. Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):215-6. Southeast Asian J Trop Med Public Health. 1994. PMID: 7825019 No abstract available.
Anton N. Hasso.
Chow D. Chow D. AJNR Am J Neuroradiol. 2024 Apr 25. doi: 10.3174/ajnr.A8266. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 38663985 No abstract available.
Through the looking glass: empowering youth community advisory boards in Tanzania as a sustainable youth engagement model to inform policy and practice.
Chow DWS, Goi A, Salm MF, Kupewa J, Mollel G, Mninda Y, Ambonisye J, Malongo A, Ketang'enyi E, Sanga E, Ngowi H, William R, Msuya E, Mmbaga BT, Mpili A, Dow DE. Chow DWS, et al. Front Public Health. 2024 Feb 27;12:1348242. doi: 10.3389/fpubh.2024.1348242. eCollection 2024. Front Public Health. 2024. PMID: 38476491 Free PMC article.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
824 results